Evaluating Strategies to Reduce Mother-to-Child Transmission of HIV Infection in Resource-Limited Countries

NCT01061151 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

3747

Enrollment

NIH

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: Zidovudine (ZDV)
DRUG: Nevirapine (NVP): Antepartum Mothers
DRUG: Emtricitabine-tenofovir disoproxil fumarate (Truvada [TRV]) tail
DRUG: Lamivudine-Zidovudine (3TC-ZDV)
DRUG: Lopinavir-ritonavir (LPV-RTV)
DRUG: Emtricitabine-tenofovir disoproxil fumarate (Truvada [TRV])
DRUG: Nevirapine (NVP): Infant short-course
DRUG: Nevirapine (NVP): Infant extended
OTHER: No Intervention
OTHER: Discontinue triple ARVs
OTHER: Continue triple ARVs

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)